Date closed: 6/22/2016

Value: US$7 million

On June 22, 2016, Aurinia Pharmaceuticals Inc.  closed a US$7,080,000 private placement. Under the terms of the Offering, the Company issued 3,000,000 units at a subscription price per Unit of US$2.36, each Unit consisting of one common share and US$0.35 of one common share purchase warrant.

BLG represented Aurinia Pharmaceuticals Inc. by Stephen P. Robertson and Michelle M. Wilkinson.